Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 159 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1581 6.5 months Advanced hepatocellular carcinoma 5 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 11/2010
Treatment Details: Patients: This phase 3 trial involved patients with hepatocellular carcinoma who had no previous systemic cancer treatment. Patients were separated into two treatment groups. Group 1 incl
 
1582 6.5 months Advanced hepatocellular carcinoma 5 Hormone
Universitaire Amiens Nord France 7/2009
Treatment Details: Patients: This phase 3 study involved 135 advanced hepatocellular carcinoma patients. The average patient age was 65 years and 81% were male. Treatment: Patients were treated with the
 
1583 6.5 months Recurrent GBM 4 Biologic therapy
Dana Farber/Brigham and Women’s Cancer Center United States 4/2011
Treatment Details: Patients: This phase 2 study involved 40 recurrent glioblastoma patients who had been previously treated. The median patient age was 54 years and 63% were male. Treatment: Patients wer
 
1584 6.5 months Advanced hepatocellular carcinoma 4 Biologic therapy
National Taiwan University Hospital Taiwan Region 1/2009
Treatment Details: Patients: This phase III study involved 150 advanced hepatocellular carcinoma patients who had no prior chemotherapy. The median age was 51 years and 84.7% were male. Treatment: Patien
 
1585 6.5 months Advanced Urothelial Cancer 4 Chemotherapy
University of Ulsan College of Medicine Korea 10/2012
Treatment Details: Patients: This phase 2 study involved 37 advanced urothelial cancer patients who were previously treated with gemcitabine and platinum-based chemotherapy. The median patient age was 57 yea
 
1586 6.5 months Metastatic colorectal cancer 4 Chemotherapy
Asturias Central University Hospital Spain 11/2014
Treatment Details: Patients: This study involved 119 previously treated, metastatic colorectal cancer patients. The median patient age was 63 years and 68.9% were male. Treatment: Patients received chemo
 
1587 6.4 months Metastatic colorecal cancer 5 Biologic therapy
Mayo Clinic United States 1/2013
Treatment Details: Patients: This phase 3 study involved 505 previously treated metastatic colorectal cancer patients. The median patient age was 61 years and 62% were male. Treatment: Patients were trea
 
1588 6.4 months SCLC 4 Chemotherapy
The Catholic University of Korea Korea 10/2013
Treatment Details: Patients: This phase 2 study involved 26 elderly (at least 65 years of age) small cell lung cancer patients who had not been previously treated; 88% of the patients were male. Treatment:
 
1589 6.4 months Malignant pleural mesothelioma 4 Chemotherapy
Istituto Oncologico Veneto Italy 9/2011
Treatment Details: Patients: This study involved 17 patients with malignant pleural mesothelioma who had previously received chemotherapy. The median patient age was 61 years and 12 were male. Treatment:
 
1590 6.4 months Metastatic melanoma 5 Immunotherapy
Dana–Farber Cancer Institute United States 8/2010
Treatment Details: Patients: This study involved metastatic melanoma patients that were positive for HLA-A*0201, which is a specific version of a gene involved in the immune response. Patients were divided i
 
Page 159 of 187  | Previous Page  | Next Page